![Peter Lockey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Lockey
Corporate Officer/Principal at Pulmagen Therapeutics (Synergy) Ltd.
Network origin in Peter Lockey first degree
Entity | Entity type | Industry | |
---|---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
![]() Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Lockey via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc.
![]() Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor | |
University of Oxford | College/University | Undergraduate Degree | |
The University of Manchester | College/University | Doctorate Degree | |
Medeval Group Ltd.
![]() Medeval Group Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, Medeval Group Ltd. is a British company that carries out clinical pharmacology studies on behalf of pharmaceutical and biotechnology companies. The company is based in Manchester, UK. Medeval Group was acquired by ICON plc on January 24, 2003 for $22.64 million. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Galapagos Biotech Ltd.
![]() Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
University of Cambridge | College/University | Undergraduate Degree | |
University of Wales, Newport | College/University | Doctorate Degree | |
The University of Sheffield | College/University | Doctorate Degree | |
University of Leicester | College/University | Undergraduate Degree | |
Pulmagen Therapeutics LLP
![]() Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Portfolio Manager-Fixed Income | |
Sygnature Discovery Ltd.
![]() Sygnature Discovery Ltd. Pharmaceuticals: MajorHealth Technology Sygnature Discovery Ltd. engages in drug discovery activities. It specializes in target validation, hit identification, hit to lead, lead optimization, integrated drug discovery, and fragment based drug discovery. The company was founded by Simon Christopher Hirst in 2004 and is headquartered in Nottingham, United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Syncona Partners LLP
![]() Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Oxford Science Enterprises PLC
![]() Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Consultant / Advisor | |
OMass Therapeutics Ltd.
![]() OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Evergreen Holdco 1 Ltd.
![]() Evergreen Holdco 1 Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Aghoco (1579) Topco Ltd., Evergreen Holdco 1 Ltd. operates as a holding British company with subsidiaries that engage in research and experimental development on biotechnology. The company is based in Nottingham, UK. | Miscellaneous Commercial Services | Director/Board Member | |
Aghoco 1566 (Bidco) Ltd.
![]() Aghoco 1566 (Bidco) Ltd. Financial ConglomeratesFinance Part of Aghoco (1579) Topco Ltd., Aghoco 1566 (Bidco) Ltd. functions as an investment holding British company. The company is based in Nottingham, UK. | Financial Conglomerates | Director/Board Member | |
Macrophox Ltd.
![]() Macrophox Ltd. BiotechnologyHealth Technology Macrophox Ltd. engages in the provision of research and experimental development on biotechnology. The company was founded on March 12, 2018 and is headquartered in Woodstock, The United Kingdom. | Biotechnology | Chairman | |
Sygil Group Ltd.
![]() Sygil Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Evergreen Holdco 2 Ltd., Sygil Group Ltd. is a holding British company that provides drug discovery services. The company is based in Nottingham, UK and was founded in 2011. | Pharmaceuticals: Major | Director/Board Member | |
Aghoco (1579) Topco Ltd.
![]() Aghoco (1579) Topco Ltd. BiotechnologyHealth Technology Aghoco (1579) Topco Ltd. is a British biotechnology company founded in 2017. The private company is based in Nottingham, UK. and has subsidiaries in United Kingdom. Aghoco engages in research and development in biotechnology. | Biotechnology | Director/Board Member | |
Aghoco 1578 (Midco) Ltd.
![]() Aghoco 1578 (Midco) Ltd. Pharmaceuticals: MajorHealth Technology Part of Aghoco (1579) Topco Ltd., Aghoco 1578 (Midco) Ltd. operates as a holding British company whose subsidiary manufactures drugs. The company is based in Nottingham, UK and was founded in 2017. | Pharmaceuticals: Major | Director/Board Member | |
RenaSci Ltd.
![]() RenaSci Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Aghoco (1579) Topco Ltd., RenaSci Ltd. provides pharmacy consulting services. The company is based in Nottingham, UK. The British company was founded in 2001 by Sharon Crawford Cheetham, Robert Brian Jones, David John Heal. | Miscellaneous Commercial Services | Director/Board Member | |
PEPGEN INC. | Biotechnology | Director/Board Member | |
ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Universite Louis Pasteur Strasbourg I | College/University | Doctorate Degree |
Statistics
International
United Kingdom | 24 |
United States | 5 |
Israel | 2 |
France | 2 |
Sectoral
Health Technology | 14 |
Consumer Services | 8 |
Commercial Services | 6 |
Finance | 5 |
Operational
Director/Board Member | 11 |
Corporate Officer/Principal | 9 |
Doctorate Degree | 4 |
Chief Executive Officer | 3 |
Undergraduate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
Christopher Ashton | 12 |
Paul Jonathan Clewlow | 12 |
David E. Clark | 5 |
Colin Graham Knox | 3 |
Lilian Alcaraz | 3 |
- Stock Market
- Insiders
- Peter Lockey
- Company connections